Thus, empagliflozin prevented development of the pathological features of NASH, suggesting that it could become a simple new therapeutic strategy for NASH associated with diabetes

Thus, empagliflozin prevented development of the pathological features of NASH, suggesting that it could become a simple new therapeutic strategy for NASH associated with diabetes. Authors contributions TJ, TT, TS, and KA collected the data. factor-, interleukin-6, and monocyte chemoattractant protein-1) was decreased IQGAP1 in the empagliflozin and linagliptin?+?empagliflozin groups compared with the vehicle group. …
Continue reading Thus, empagliflozin prevented development of the pathological features of NASH, suggesting that it could become a simple new therapeutic strategy for NASH associated with diabetes